Driven by theses insights, we aimed to elucidate the molecular mechanism by which Notch signaling in TAMs regulates tumor growth and how HES1 deficiency alters the TME into an immunostimulatory state to assess the potential of HES1 targeting for novel cancer immunotherapy strategies. Here, HES1 is linked to neoplasm.